Prevalence and clinical outcomes of white‐coat and masked hypertension: Analysis of a large ambulatory blood pressure database. Issue 2 (25th January 2018)

• Record Type: Journal Article
• Authors: Tocci, Giuliano; Presta, Vivianne; Figliuzzi, Ilaria; Attalla El Halabieh, Nadia; Battistoni, Allegra; Coluccia, Roberta; D'Agostino, Michela; Ferrucci, Andrea; Volpe, Massimo
• Is Part Of: Journal of clinical hypertension. Volume 20:Issue 2(2018)
• Page Start: 297
• Page End: 305
• Publication Date: 2018-01-25
• Subjects: ambulatory blood pressure monitoring -- hospitalizations -- masked hypertension -- myocardial infarction -- stroke -- sustained hypertension -- white‐coat hypertension; Hypertension -- Periodicals; 616.132
• DOI: 10.1111/jch.13181
• Languages: English
• ISSNs: 1524-6175

Abstract

Abstract : The aim of this study was to analyze prevalence and clinical outcomes of the following clinical conditions: normotension (NT; clinic BP < 140/90 mm Hg; 24‐hour BP < 130/80 mm Hg), white‐coat hypertension (WCHT; clinic BP ≥ 140 and/or ≥90 mm Hg; 24‐hour BP < 130/80 mm Hg), masked hypertension (MHT; clinic BP < 140/90 mm Hg; 24‐hour BP ≥ 130 and/or ≥80 mm Hg), and sustained hypertension (SHT; clinic BP ≥ 140 and/or ≥90 mm Hg; 24‐hour BP ≥ 130 and/or ≥80 mm Hg) in a large cohort of adult untreated individuals. Systematic research throughout the medical database of Regione Lazio (Italy) was performed to estimate incidence of myocardial infarction (MI), stroke, and hospitalizations for HT and heart failure (HF). Among a total study sample of 2209 outpatients, 377 (17.1%) had NT, 351 (15.9%) had WCHT, 149 (6.7%) had MHT, and 1332 had (60.3%) SHT. During an average follow‐up of 120.1 ± 73.9 months, WCHT was associated with increased risk of hospitalization for HT (OR 95% CI: 1.927 [1.233‐3.013]; P = .04) and HF (OR 95% CI: 3.449 [1.321‐9.007]; P = .011). MHT was associated with an increased risk of MI (OR 95% CI: 5.062 [2.218‐11.550]; P < .001), hospitalization for HT (OR 95% CI: 2.553 [1.446‐4.508]; P = .001), and for HF (OR 95% CI: 4.214 [1.449‐12.249]; P = .008). These effects remained statistically significant event after corrections for confounding factors including age, BMI, gender, smoking, dyslipidaemia, diabetes, and presence of antihypertensive therapies.